{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:02:54Z","timestamp":1740128574820,"version":"3.37.3"},"reference-count":24,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#DA046051"],"award-info":[{"award-number":["#DA046051"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Toxicology"],"published-print":{"date-parts":[[2021,4,3]]},"DOI":"10.1080\/15563650.2020.1803350","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T13:47:47Z","timestamp":1598363267000},"page":"313-319","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling"],"prefix":"10.1080","volume":"59","author":[{"given":"Alice","family":"Wu","sequence":"first","affiliation":[{"name":"Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Phan","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim Chi","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin","family":"Quindoy","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Lewis","sequence":"additional","affiliation":[{"name":"California Poison Control System \u2013 Sacramento Division, University of California Davis Medical Center, Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-0826","authenticated-orcid":false,"given":"Dorie E.","family":"Apollonio","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"issue":"10","key":"CIT0001","first-page":"1","volume":"65","author":"Warner M","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"CIT0002","unstructured":"Drug Scheduling. [cited 2020 May 11]. Available from: https:\/\/www.dea.gov\/drug-scheduling"},{"key":"CIT0003","unstructured":"DEA To Publish Final Rule Rescheduling Hydrocodone Combination Products. [cited 2020 May 11]. Available from: https:\/\/www.dea.gov\/press-releases\/2014\/08\/21\/dea-publish-final-rule-rescheduling-hydrocodone-combination-products"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.5.532"},{"key":"CIT0005","unstructured":"DEA Final Rule Rescheduling Hydrocodone Combination Products; 2014. Available from: https:\/\/www.asahq.org\/-\/media\/sites\/asahq\/files\/public\/advocacy\/federal-activities\/regulatory-activities\/pain-medicine\/rescheduling-hydrocodone-products.pdf."},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2016.11929431"},{"issue":"4","key":"CIT0007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5055\/jom.2018.0457","volume":"14","author":"Shumway JW","year":"2018","journal-title":"J Opioid Manag"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz210"},{"issue":"10","key":"CIT0009","first-page":"449","volume":"70","author":"Kuschel LM","year":"2017","journal-title":"S D Med"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4376"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2019.1574976"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2016.1148720"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15020262"},{"key":"CIT0014","unstructured":"American Association of Poison Control Centers (AAPCC) - Notes About Poison Control Data. [cited 2020 May 11]. Available from: https:\/\/aapcc.org\/datainfo"},{"key":"CIT0015","unstructured":"Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations. [cited 2020 May 11]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4622415\/"},{"issue":"4","key":"CIT0016","first-page":"235","volume":"42","author":"Choy M.","year":"2017","journal-title":"Pharm Ther"},{"key":"CIT0017","unstructured":"American Association of Poison Control Centers. 2019. National Poison Data System (NDPS) Coding User\u2019s Manual Version 4.1 (April 16). Available from: https:\/\/bezoar.georgiapoisoncenter.org\/wp-content\/uploads\/2014\/07\/NPDS-2019.pdf"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1501500208"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12131"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2270"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.050"},{"key":"CIT0022","unstructured":"California\u2019s Activities. [cited 2020 May 11]. Available from: https:\/\/www.cdph.ca.gov\/Programs\/CCDPHP\/DCDIC\/SACB\/Pages\/CaliforniasStrategiesAndActivities.aspx"},{"key":"#cr-split#-CIT0023.1","unstructured":"National Institute on Drug Abuse. Overdose Death Rates. [Published 2020 Mar 10"},{"key":"#cr-split#-CIT0023.2","unstructured":"cited 2020 May 11]. Available from: https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"}],"container-title":["Clinical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15563650.2020.1803350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:07:08Z","timestamp":1696579628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15563650.2020.1803350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,3]]}},"alternative-id":["10.1080\/15563650.2020.1803350"],"URL":"https:\/\/doi.org\/10.1080\/15563650.2020.1803350","relation":{},"ISSN":["1556-3650","1556-9519"],"issn-type":[{"type":"print","value":"1556-3650"},{"type":"electronic","value":"1556-9519"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}